EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hemodiafiltration: Technical and Medical Insights

Thomas Lang, Adam M Zawada iD, Lukas Theis, Jennifer Braun, Bertram Ottillinger iD, Pascal Kopperschmidt, Alfred Gagel iD, Peter Kotanko, Manuela Stauss-Grabo, James P Kennedy, Bernard Canaud iD

Bioengineering · 21.01.2023 · 10 (2) · 145

DOI: 10.3390/bioengineering10020145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering, online erschienen am 21.01.2023. Verfasst von Thomas Lang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Global Biomedical Evidence Generation, Fresenius Medical Care Deutschland GmbH, 61352 Bad Homburg, Germany. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the significant medical and technical improvements in the field of dialytic renal replacement modalities, morbidity and mortality are excessively high among patients with end-stage kidney disease, and most interventional studies yielded disappointing results. Hemodiafiltration, a dialysis method that was implemented in clinics many years ago and that combines the two main principles of hemodialysis and hemofiltration—diffusion and convection—has had a positive impact on mortality rates, especially when delivered in a high-volume mode as a surrogate for a high convective dose. The achievement of high substitution volumes during dialysis treatments does not only depend on patient characteristics but also on the dialyzer (membrane) and the adequately equipped hemodiafiltration machine. The present review article summarizes the technical aspects of online hemodiafiltration and discusses present and ongoing clinical studies with regards to hard clinical and patient-reported outcomes.

Schlagwörter

Stichwörter der Autor:innen

convection volumedialysisend-stage kidney diseasehemodiafiltrationperformance

Autor:innen und Institutionen

  • Global Biomedical Evidence Generation, Fresenius Medical Care Deutschland GmbH, 61352 Bad Homburg, Germany.
  • Product Development, Fresenius Medical Care Deutschland GmbH, 66606 Sankt Wendel, Germany.
  • Ottillinger Life Sciences, 85649 Brunnthal, Germany.
  • Hemodialysis Machines Germany Innovative Technology, Fresenius Medical Care Deutschland GmbH, 97424 Schweinfurt, Germany.
  • Hemodialysis Machines Global Systems Engineering, Fresenius Medical Care Deutschland GmbH, 97424 Schweinfurt, Germany.
  • Renal Research Institute, New York, NY 10065, USA.

ORCID-Profile: Adam M Zawada, Bertram Ottillinger, Alfred Gagel, Bernard Canaud

Zitieren

APA

Lang, T., Zawada, A. M., Theis, L., Braun, J., Ottillinger, B., Kopperschmidt, P., Gagel, A., Kotanko, P., Stauss-Grabo, M., Kennedy, J. P., & Canaud, B. (2023). Hemodiafiltration: Technical and Medical Insights. Bioengineering, 10(2), 145. https://doi.org/10.3390/bioengineering10020145

Vancouver

Lang T, Zawada AM, Theis L, Braun J, Ottillinger B, Kopperschmidt P, et al. Hemodiafiltration: Technical and Medical Insights. Bioengineering. 2023;10(2):145. doi:10.3390/bioengineering10020145

BibTeX
@article{Lang2023,
  author = {Lang, Thomas and Zawada, Adam M and Theis, Lukas and Braun, Jennifer and Ottillinger, Bertram and Kopperschmidt, Pascal and Gagel, Alfred and Kotanko, Peter and Stauss-Grabo, Manuela and Kennedy, James P and Canaud, Bernard},
  title = {Hemodiafiltration: Technical and Medical Insights},
  journal = {Bioengineering},
  year = {2023},
  volume = {10},
  number = {2},
  pages = {145},
  doi = {10.3390/bioengineering10020145}
}
Kostenlos starten →